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The number of resident macrophages (Ms) in 
several tissues can apparently be maintained with­
out replenishment from blood monocytes and 
other hematopoietic precursors (Volkman et al., 
1983; Kanitakis et al., 2004; Ajami et al., 2007; 
Klein et al., 2007; Murphy et al., 2008; Schulz 
et al., 2012; Yona et al., 2013) through in situ 
proliferation (Chorro et al., 2009; Davies et al., 
2011; Jenkins et al., 2011; Hashimoto et al., 2013). 
Local proliferation restores homeostatic num­
bers of resident lung and peritoneal Ms after 
their loss as a result of acute inflammation 
(Davies et al., 2011; Hashimoto et al., 2013) but 
can act also as an inflammatory mechanism, 
leading to an outgrowth of tissue­resident Ms 
beyond homeostatic levels. For example, infection 
with the rodent filarial nematode Litomosoides 
sigmodontis (Ls) causes a pleuritis characterized 
by expansion of the resident M population 
to high densities equivalent to that reached by 
recruited monocyte­derived Ms during clas­
sical inflammation (Jenkins et al., 2011). Sim­
ilarly, Langerhans cells and microglia increase in 
density via elevated self­renewal during atopic 
dermatitis and experimental autoimmune en­
cephalitis, respectively (Chorro et al., 2009; Ajami 
et al., 2011).
Proliferation, differentiation, and survival of 
Ms are controlled by the CSF1R ligands CSF­1 
and IL­34 produced by local tissue stroma to 
regulate the density of resident Ms (Hume 
and MacDonald, 2012). CSF­1 administration to 
mice can increase blood monocyte and tissue 
M numbers (Hume et al., 1988). Mice lacking 
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Macrophages (Ms) colonize tissues during inflammation in two distinct ways: recruitment 
of monocyte precursors and proliferation of resident cells. We recently revealed a major role 
for IL-4 in the proliferative expansion of resident Ms during a Th2-biased tissue nematode 
infection. We now show that proliferation of Ms during intestinal as well as tissue nema-
tode infection is restricted to sites of IL-4 production and requires M-intrinsic IL-4R sig-
naling. However, both IL-4R–dependent and –independent mechanisms contributed to M 
proliferation during nematode infections. IL-4R–independent proliferation was controlled by 
a rise in local CSF-1 levels, but IL-4R expression conferred a competitive advantage with 
higher and more sustained proliferation and increased accumulation of IL-4R+ compared 
with IL-4R cells. Mechanistically, this occurred by conversion of IL-4R+ Ms from a 
CSF-1–dependent to –independent program of proliferation. Thus, IL-4 increases the relative 
density of tissue Ms by overcoming the constraints mediated by the availability of CSF-1. 
Finally, although both elevated CSF1R and IL-4R signaling triggered proliferation above 
homeostatic levels, only CSF-1 led to the recruitment of monocytes and neutrophils. Thus, 
the IL-4 pathway of proliferation may have developed as an alternative to CSF-1 to increase 
resident M numbers without coincident monocyte recruitment.
© 2013 Jenkins et al. This article is distributed under the terms of an Attribution– 
Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.rupress.org/terms). After six months 
it is available under a Creative Commons License (Attribution–Noncommercial– 
Share Alike 3.0 Unported license, as described at http://creativecommons.org/ 
licenses/by-nc-sa/3.0/).
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entirely independent of the CSF1R. However, these experiments 
revealed a significant contribution of IL­4R–independent, 
CSF1R­dependent M proliferation during nematode infec­
tion. We further demonstrate that IL­4R expression confers 
a major competitive advantage to Ms, such that IL­4R+ cells 
rapidly outcompete those lacking receptor expression.
RESULTS
IL-4–dependent proliferation does not require the CSF1R
We used delivery of IL­4c as a reductionist approach to inves­
tigate whether IL­4 acts via the CSF1R to drive expansion 
of resident serous cavity Ms. Ki67 expression was used to 
determine the frequency of all F4/80High Ms in cycle, as 
described previously (Jenkins et al., 2011), whereas a 3­h 
BrdU pulse before necropsy or high level of Ki67 expression 
(Ki67High) was used to identify cells in S phase (Fig. S1 A; 
Landberg et al., 1990). Intracellular staining for RELM and/or 
Ym1 was used as a marker of alternative activation. Consis­
tent with the established role of CSF­1 in regulating steady­
state M levels (Davies et al., 2013), proliferation observed in 
control PBS­treated mice was completely blocked by treat­
ment with anti­CSF1R mAb (Fig. 1 A). In contrast, neither 
elevated proliferation nor marker induction by IL­4c was 
affected by antibody treatment (Fig. 1 A). The only influence 
of blocking CSF1R on IL­4c treatment was to reduce the 
final M number (Fig. 1 A). Daily oral gavage of GW2580, 
an inhibitor of the CSF1R tyrosine kinase, also had no effect 
on IL­4–induced M proliferation or alternative activation 
(Fig. 1 B). Furthermore, Csf1r gene expression was significantly 
reduced in FACS­purified peritoneal Ms 24 h after injection 
of IL­4c (Fig. 1 C). As expected, because the ligand is cleared 
by receptor­mediated endocytosis (Hume and MacDonald, 
2012), CSF1R blockade resulted in elevated levels of CSF­1 
in the tissue and bloodstream (Fig. 1 D), thereby confirming 
the effectiveness of the antibody. However, CSF­1 production 
was not increased in response to IL­4 (Fig. 1 D). Thus, in the 
context of IL­4 delivery, there was no evidence of CSF1R in­
volvement in proliferation and alternative activation.
IL-4–driven proliferation requires  
M-intrinsic IL-4R signaling
We next addressed the possibility that IL­4 signals directly to 
Ms to induce proliferation. We used LysMcreIl4ra/lox mice to 
delete the IL­4R chain on myeloid cells including Ms 
and neutrophils (Herbert et al., 2004). Injection of IL­4c into 
LysMcreIl4ra/lox mice resulted in elevated proliferation of 
F4/80High Ms in the cavities as well as elevated frequencies 
of alternatively activated Ms (Fig. 2 A). Nevertheless, M 
proliferation was lower in LysMcreIl4ra/lox mice than in Il4ra/lox 
controls (pleural, P < 0.01; peritoneal, P < 0.001; Fig. 2 B). 
Co­staining for RELM and BrdU (Fig. 2 B) revealed 
that RELM+ Ms from LysMcreIl4ra/lox mice underwent 
significantly greater levels of proliferation than RELM 
cells. Because RELM expression is a known marker of 
IL­4R engagement on Ms (Jenkins and Allen, 2010) and 
LysM­Cre is relatively inefficient (Hume, 2011), the data 
the CSF1R exhibit an extreme deficit in resident Ms in 
many tissues (Dai et al., 2002), and the same cells are ablated 
in a time­dependent manner after treatment with a blocking 
anti­CSF1R antibody (MacDonald et al., 2010). A proliferative 
signal through the CSF1R has been shown to maintain ho­
meostatic numbers of resident peritoneal Ms in the steady­
state (Davies et al., 2013) and mediate repopulation of resident 
lung and peritoneal Ms after acute inflammation or experi­
mental depletion (Davies et al., 2013; Hashimoto et al., 2013). 
CSF1R signaling can also control in vivo proliferation of 
monocyte­derived Ms, required for the population of the 
growing myometrium in pregnancy (Tagliani et al., 2011) or 
maintenance of recruited cells during the resolution phase 
of sterile peritonitis (Davies et al., 2013).
The Th2 lymphokine IL­4 was first shown to regulate 
proliferation and accumulation of resident Ms in the con­
text of filarial nematode infection. Moreover, serial adminis­
tration of an rIL­4 complex (IL­4c) was sufficient to induce 
proliferation and accumulation of Ms throughout the body, 
including in the peritoneal cavity and liver (Jenkins et al., 
2011), lung, and spleen (unpublished data), and to drive pro­
liferation of recruited monocyte­derived cells (Jenkins et al., 
2011). These studies did not reveal whether the actions of 
IL­4 were direct or indirect.
Akt signaling is required for CSF­1–mediated prolifera­
tion (Smith et al., 2000; Irvine et al., 2006; Huynh et al., 
2012), and we have recently shown that intact Akt signaling is 
critically important for in situ M proliferation in response 
to IL­4 (Rückerl et al., 2012). However, IL­4 receptor (IL­4R) 
signaling does not effectively activate Akt in Ms in vitro de­
spite phosphorylating PKB (Heller et al., 2008), thus raising 
the possibility that IL­4 acts via CSF1R signaling to induce 
Akt­dependent M proliferation. Indeed, many important 
parallels exist between IL­4– and CSF­1–activated Ms. For 
example, both IL­4 and CSF­1 promote a suppressive and a 
pro­repair phenotype in Ms (Alikhan et al., 2011). Further­
more, the transcription factors c­Myc and KLF­4 are critical 
for both the “alternative activation” state induced in Ms by 
engagement of the IL­4R (Liao et al., 2011; Pello et al., 2012) 
and CSF­1–dependent proliferation that occurs in the absence 
of Maf B and c­Maf (Aziz et al., 2009). Thus, understand­
ing the relationship between CSF­1 and IL­4 is important, 
not least because several groups have used CSF­1 to generate 
human “M2” Ms (Verreck et al., 2004; Martinez et al., 2006; 
Fleetwood et al., 2007), which are often considered highly par­
allel to alternatively activated Ms driven by IL­4.
This study seeks to determine the contribution of CSF­1 
to IL­4–driven M proliferation and alternative activation. 
Alternatively activated Ms are a distinguishing feature of 
inflammation driven by helminth infections and allergy but 
may also appear in cold­stressed adipose tissue (Nguyen et al., 
2011; Karp and Murray, 2012), certain immunogenic tumors 
(DeNardo et al., 2009; Linde et al., 2012), and even the steady­
state (Wu et al., 2011). Using direct delivery of IL­4 and Th2­
biased infection models, we demonstrate that IL­4–mediated 
proliferation requires M­intrinsic IL­4R signaling that is 
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context. Intracellular staining for RELM (not depicted) 
and Ym1 (Fig. 2 E) in these experiments confirmed an abso­
lute requirement for intrinsic IL­4R signaling to up­regulate 
production of these archetypal alternative activation markers 
under this reductionist condition.
Both IL-4R–dependent and –independent pathways 
contribute to proliferation during nematode infection
The Th2 cytokines IL­4 and IL­13 can both signal via the 
IL­4R to drive alternative activation (Gordon and Martinez, 
2010). In our previous study, nematode­associated increased 
M proliferation was not entirely absent in Il4/ mice (Jenkins 
et al., 2011), suggesting a possible contribution from IL­13. 
To assess the potential of IL­13 to induce proliferation, mice 
were injected with IL­13 complexed with a neutralizing anti­
body (IL­13c). IL­13c led to significant (P < 0.01) M pro­
liferation, at a similar magnitude to IL­4c delivery (Fig. 3 A), 
but as documented previously (Heller et al., 2008), IL­13 was 
somewhat less effective at stimulating RELM production 
by Ms. To determine whether IL­13 was responsible for the 
residual rise in proliferation observed in nematode­infected 
Il4/ mice, we infected mice lacking the IL­4R chain 
(Il4ra/). Proliferation and accumulation of pleural Ms 
after Ls infection were significantly (P < 0.001) reduced in 
Il4ra/ mice compared with WT controls (Fig. 3 B) but to 
no greater extent than in the Il4/ mice (Jenkins et al., 2011), 
suggesting no contribution of IL­13. In contrast, marker 
induction in Ms was entirely dependent on IL­4R signaling 
suggest that IL­4–dependent proliferation predominantly 
occurs in the subset of Ms that retain the IL­4R in LysMcre 
Il4ra/lox animals.
To confirm this conclusion, Il4ra+/+Cd45.1+Cd45.2+ 
C57BL/6 mice were lethally irradiated and transplanted with 
a 50:50 mix of BM from Il4ra+/+Cd45.1+Cd45.2+ and Il4ra/ 
Cd45.2+/+Cd45.1null mice, so that cells derived from Il4ra/ 
BM could be distinguished from WT by a lack of CD45.1 
expression. Blood­borne monocytes (Fig. 2 C) and other 
myeloid populations (not depicted) exhibited roughly equal 
proportions of CD45.1+ and CD45.1 cells 8 wk after recon­
stitution. This extends earlier data showing the key mediator 
of IL­4R signaling, STAT6, has no intrinsic role in steady­
state proliferation or survival of hematopoietic stem cells 
despite their ubiquitous IL­4R+ expression (Bunting et al., 
2004). Likewise, similar frequencies of Il4ra+/+ and Il4ra/ 
cells were detected in the resident F4/80High pleural and peri­
toneal cavity M populations in control mice treated with 
PBS (Fig. 2 D and not depicted). In contrast, Il4ra+/+  
F4/80High Ms greatly outnumbered Il4ra/ cells in the 
pleural and peritoneal cavities of mice treated with IL­4c. 
Indeed, only the IL­4R+ population increased in number 
after treatment with IL­4c (Fig. 2 D and not depicted), consis­
tent with increased S­phase BrdU+ cells (Fig. 2 E) and Ki67+ 
cells (not depicted) being observed only in the CD45.1+ 
IL­4R+ cells. Notably, steady­state levels of proliferation in 
PBS­treated controls did not differ between Il4ra+/+ and Il4ra/ 
cells, suggesting IL­4 is only important in an inflammatory 
Figure 1. IL-4 drives CSF-1–independent 
M proliferation. (A) BL/6 mice were in-
jected i.p. with IL-4c or PBS plus anti-CSF1R 
mAb (CSF1R), rat IgG (RIgG), or PBS on days 
0 and 2. The proportion of F4/80High pleural 
Ms positive for Ki67, Ki67High, or RELM 
and total M numbers were determined by 
flow cytometry on day 2 after the last injec-
tion. Graphs depict individual data for four 
mice/group. (B) As in A, but on day 3 after 
daily oral gavage with vehicle control or 
GW2580 on days 0–3. (C) Mice were injected 
with a single dose of PBS or IL-4c, and the 
expression of CSF1R mRNA was determined 
24 h later in FACS-purified F4/80High perito-
neal Ms. ***, P < 0.001 determined by two-
tailed Student’s t test. Individual data for five 
mice/group are shown. (D) CSF-1 levels in 
pleural lavage fluid and serum from mice in A 
determined by ELISA. All data are representa-
tive of two to three separate experiments, 
with the same results observed in the perito-
neal cavity. (A–D) Horizontal bars indicate 
mean values.
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by IL­4c versus Ls infection revealed key differences: IL­4c 
induced marker expression in peritoneal and pleural Ms 
before detectable proliferation (Fig. 3 C and Fig. S1 B), whereas 
during infection proliferation preceded marker expression 
(Fig. 3 D). The data indicate that IL­4R–independent 
(Fig. 3 B), and worm burdens did not significantly differ be­
tween strains at this stage of infection (not depicted). Hence, 
mechanisms independent of IL­4R contribute to elevated 
M self­renewal during nematode infection. Comparison of the 
kinetics of alternative activation and proliferation stimulated 
Figure 2. M-intrinsic IL-4R signaling is essential for proliferation and alternative activation triggered by IL-4c. (A) LysMcreIl4ra/lox BALB/c 
mice were injected i.p. on days 0 and 2 with PBS or IL-4c, and peritoneal lavage cells were analyzed on day 4 by flow cytometry for BrdU incorporation or 
Ki67, RELM, and Ym1 versus F4/80 expression. Representative flow cytograms gated on F4/80High peritoneal Ms with frequencies depicting the mean ± 
SEM of four mice per group. (B) Il4ra/lox (Het), LysMcreIl4ra/lox (Lys), or Il4ra/ (/) BALB/c were treated with PBS (open) or IL-4c (closed) as in A, and 
BrdU incorporation by F4/80High pleural Ms was determined on day 3 together with the frequency of BrdU+ cells in RELM-positive (+) or negative () 
F4/80High Ms from the IL-4c–treated LysMcreIl4ra/lox group. *, P < 0.05; **, P < 0.01; and ***, P < 0.001 determined by ANOVA (left) or paired Student’s  
t test (right). Data are representative of four independent experiments inclusive of data in A, with three to four mice/group. (C) BL/6 Il4ra+/+Cd45.1+Cd45.2+ 
mice were lethally irradiated and reconstituted with a 50:50 mix of Il4ra+/+Cd45.1+Cd45.2+ and Il4ra/Cd45.1nullCd45.2+/+ congenic BM cells. The fre-
quency of blood monocytes (gated as side scatter [SSC]lowCD11b+CD115+) derived from each BM was determined by analysis of CD45.1 and CD45.2  
expression 8 wk later. A representative flow cytogram of CD45.1 and CD45.2 expression on blood monocytes is shown together with a graph depicting 
the frequency of CD45.1+ and CD45.1 monocytes in all blood leukocytes from 10 individual mice. (D) Mice from C were subsequently injected i.p. twice, 
2 d apart, with PBS or IL-4c, and pleural lavage cells were analyzed 2 d after the last injection for CD45.1 and CD45.2 expression. Representative flow cyto-
grams gated on all live F4/80High Ms are shown together with a graph depicting the total number of Il4ra+/+Cd45.1+ (closed circles) and Il4ra/Cd45.1null 
(open circles) pleural F4/80High Ms in each group, with individual data for five mice/group presented. (E) Representative flow cytograms depicting 
CD45.1 expression versus BrdU incorporation or Ym1 expression gated on single F4/80HighCD19 pleural Ms from mice in D, and graphs showing the 
proportion of Il4ra+/+Cd45.1+ (closed circles) and Il4ra/Cd45.1null (open circles) F4/80HighCD19 Ms positive for BrdU or Ym1 for individual mice.  
(C–E) Data are representative of two experiments. (B–E) Horizontal bars indicate mean values.
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sustained (Fig. 3 C and Fig. S1 B). After two sequential IL­4c 
doses at days 0 and 2, proliferation remained evident at 
day 4 (Fig. 1 A). We therefore titrated the dose of IL­4c. As 
expected, proliferative activity required high doses of IL­4, 
proliferation occurs early during infection with subsequent 
peak proliferation driven by IL­4.
Of note, proliferation induced by a single IL­4c dose sub­
sided after 4 d, whereas alternative activation markers were 
Figure 3. IL-4R–dependent and –independent 
mechanisms of proliferation during nematode in-
fection. (A) BL/6 mice were given a single i.p. injection 
of IL-13c, IL-4c, or PBS, and the proportion of BrdU+, 
Ki67+, and RELM+ F4/80High peritoneal Ms was de-
termined 36 h later. Graphs depict individual data for 
six mice per group and are representative of two inde-
pendent experiments. Horizontal bars indicate median 
values. Equivalent results were obtained in the pleural 
cavity. *, P < 0.05; **, P < 0.01; and ***, P < 0.001 deter-
mined by Kruskal-Wallis test. (B) C57BL/6 (WT) and 
Il4ra/ (/) mice were infected with Ls, and the 
total number of F4/80High pleural Ms and the propor-
tion positive for BrdU, Ki67, and RELM were deter-
mined on day 10. Results are pooled from two 
experiments with 15–16 mice/group shown. Horizontal 
bars indicate mean values. **, P < 0.01; and ***, P < 
0.001 determined by ANOVA. (C) BL/6 mice were given 
a single i.p. dose of IL-4c (solid line) or PBS (dashed 
line), after which the total number of pleural cavity 
F4/80High Ms and the proportion positive for RELM, 
Ki67High, or Ki67 were determined over a 4-d time 
course. Data are mean ± SEM of four mice/group and 
representative of two experiments, with the same re-
sults obtained for peritoneal Ms. Day 0 represents 
naive. (D) As C but from Ls-infected (solid line) or naive 
(dashed line) mice. Data are mean ± SEM from four to 
five mice per group and representative of three experi-
ments. (E) Representative flow cytograms of F4/80High 
peritoneal Ms 4 d after i.p. injection of PBS or IL-4c 
containing 5, 1.25, or 0.31 µg IL-4 on days 0 and 2. 
Frequencies are means with SEM in parentheses of 
three to six IL-4c–treated animals per group or a single 
value for pooled cells from three PBS-treated mice.  
A repeat using a single injection regimen verified dose 
effect for both of IL-4c and IL-13c.
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mice at this time (P < 0.001), and only in these cells did 
heightened proliferation remain evident at day 16 (Fig. 5 A). 
In contrast, production of Ym1 (Fig. 5 A) and RELM (not 
depicted) during infection was wholly dependent on M­
intrinsic IL­4R signaling. Consistent with the pattern of 
proliferation, both Il4ra+/+ and Il4ra/ populations signif­
icantly increased in number in the pleural cavity by day 10 
after infection (P < 0.01), yet by day 16 the IL­4R Ms, 
although still elevated in number (P < 0.05), were signifi­
cantly outnumbered by the IL­4R+ cells (Fig. 5 B; P < 0.05). 
The selective advantage provided by the IL­4R was only 
observed in the F4/80High M population and not in other my­
eloid cells (Fig. 5 C). Thus, although confirming the existence 
of an IL­4R–independent pathway of proliferation, these data 
show that direct IL­4R signaling to Ms conveys a com­
petitive advantage during infection at least in part by enhancing 
entry into cell cycle. These findings explain the emergence of 
whereas induction of RELM was maximal at the lowest 
dose tested (Fig. 3 E). Thus, detection of alternative activation 
markers in the tissues is not synonymous with proliferation, 
as marker expression may only indicate prior or low­level ex­
posure to IL­4.
IL-4 switches Ms to CSF-1–independent proliferation
We used CSF1R blockade to assess the potential contribution 
of CSF1R signaling to the IL­4R–independent proliferation 
that occurs during Ls infection. Mice were treated with anti­
CSF1R mAb between days 8 and 10 to coincide with the ap­
proximate onset of alternative activation (Fig. 3 D) and when 
IL­4R–independent proliferation is detectable (Fig. 3 B). 
CSF1R blockade led to a significant reduction in infection­
induced proliferation of pleural Ms (Fig. 4 A), whereas 
alternative activation (Fig. 4 A), Th2 responses, and worm 
burden (not depicted) were unaffected. However, the response 
in the infected group appeared bimodal, with 13 of 20 anti­
CSF1R–treated mice showing almost complete inhibition of 
proliferation (Fig. 4 A, black squares), whereas the remaining 
animals were similar to controls (Fig. 4 A, gray squares). The 
anti­CSF1R–treated infected animals in which high­level 
proliferation remained evident showed the highest frequencies 
of Ym1+ Ms (Fig. 4 A, gray squares), and indeed the fre­
quency of Ms able to proliferate in the presence of anti­
CSF1R correlated positively with Ym1+ Ms (Spearman 
r = 0.84, P < 0.0001). The data suggest that as the strength of 
Th2 response and corresponding IL­4R signaling increased, 
the dependence on CSF1R signaling for Ms to proliferate and 
accumulate during tissue nematode infection declined. In 
other words, IL­4 can substitute for CSF­1.
CSF­1 is increased in the circulation and local lesions 
in many infections, chronic inflammation, and malignancy 
(Chitu and Stanley, 2006; Hume and MacDonald, 2012). We 
therefore measured levels of cytokine in the pleural lavage 
fluid and serum. There was a modest increase in accumulation 
of CSF­1 in the pleural cavity of infected anti­CSF1R–treated 
mice compared with naive controls, but no increase in the 
serum (Fig. 4 B). No correlation was found between the level of 
pleural CSF­1 and frequency of BrdU+ Ms in anti­CSF1R–
treated infected mice (Spearman r = 0.1398, P = 0.5565), 
consistent with IL­4R signaling controlling CSF­1–independent 
proliferation in these mice directly rather than via elevation 
of CSF­1.
IL-4R expression provides a competitive advantage  
to Ms during nematode infection
We next infected Il4ra+/+Cd45.1+: Il4ra/Cd45.1null mixed 
BM chimeric mice with Ls to investigate the relevance of 
M­intrinsic IL­4R signaling in a setting in which IL­4R–
independent proliferation can occur. In contrast to the highly 
restricted response seen in these mice after IL­4c injection 
(Fig. 2, D and E), increased proliferation of both Il4ra+/+ and 
Il4ra/ pleural F4/80High Ms was evident by day 10 after Ls 
infection (Fig. 5 A). However, the frequency of cycling cells was 
significantly greater in the IL­4R+ population in all infected 
Figure 4. Elevated CSF-1 production contributes to M prolifera-
tion during tissue nematode infection. (A) BL/6 mice were infected 
with Ls and injected i.p. on day 8 with anti-CSF1R mAb (CSF1R), rat IgG 
(RIgG), or PBS. Total number of F4/80High pleural Ms and the proportion 
positive for BrdU, Ki67, or Ym1 were determined on day 10. Data are 
pooled from two experiments with 7, 13, and 20 mice for naive and PBS-, 
RIgG-, and anti-CSF1R–treated infected, groups, respectively. *, P < 0.05; 
and **, P < 0.01 determined by Kruskal-Wallis test. (B) CSF-1 levels in 
pleural lavage (left) or serum (right) from mice in A determined by ELISA. 
(A and B) Horizontal bars indicate median.
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Figure 5. IL-4R signaling to Ms provides a competitive advantage during tissue nematode infection. (A) BL/6 Il4ra+/+Cd45.1+Cd45.2+ mice 
were lethally irradiated and reconstituted with a 50:50 mix of Il4ra+/+Cd45.1+Cd45.2+ and Il4ra/Cd45.1nullCd45.2+/+ congenic BM cells over 8 wk. Mice 
were infected with Ls, after which BrdU incorporation or Ym1 expression versus expression of CD45.1 was determined on single F4/80HighCD19 pleural 
Ms at days 10 and 16 after infection. Representative flow cytograms are shown, whereas graphs depict the proportion of IL-4R+CD45.1+ (closed 
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in our Ls model. Infection led to a two­ to threefold in­
crease in cells in the peritoneal lavage, exclusively within the 
F4/80High M population. As expected for a Th2 setting, these 
Ms expressed RELM and Ym1 (Fig. 6 A). As in the Ls 
model, Il4/ mice had a reduced response, although a sig­
nificant increase in BrdU+ (P < 0.001), Ki67+ (P < 0.001), and 
total Ms (P < 0.01) remained (Fig. 6 B). A minor popula­
tion of Ym1+ Ms was also detected in infected Il4/ mice, 
suggesting a limited influence of IL­13 (Fig. 6 B). Blockade of 
CSF1R signaling demonstrated a CSF1R­dependent com­
ponent to the proliferative but not the alternative activation 
response (Fig. 6 C), and thus as in the Ls model, both CSF1R 
and IL­4R signaling also contribute to M proliferation in 
this model. We also reexamined the relative importance of cell­
autonomous IL­4R signaling in the Hp model. The majority 
of F4/80High Ms, but not other myeloid cell populations, 
were IL­4R+ by day 14 after infection of Il4ra+/+Cd45.1+: 
Il4ra/Cd45.1null mixed BM chimeric mice, despite earlier 
accumulation of both IL­4R+ and IL­4R cells (Fig. 6 D). 
This competitive advantage was confirmed using LysMcreIl4ra/lox 
mice infected with Hp, in which the proportion of RELM­
positive cells increased from 4% in naive mice (not depicted) 
to 25% at day 14 and 70% by day 28 (Fig. 6 E), by which point 
>50% of the Ms expressed IL­4R detectable by flow cy­
tometry (not depicted). Infection with a GI nematode thus 
led to a M response in the peritoneal cavity that mirrored 
the pleural cavity during infection with the filarial worm Ls. 
In both models, CSF1R and IL­4R contributed indepen­
dently to proliferation.
Differing consequences of CSF-1–  
versus IL-4-induced inflammation
Because both IL­4 and CSF­1 can induce local M prolifer­
ation, we sought to compare the Ms elicited by the two 
stimuli. To assess the contribution of CSF­1 to cellular dy­
namics in the serous cavity, we used a new reagent, Fc–CSF­1 
designed for stable in vivo delivery of CSF­1. We compared 
Fc–CSF­1 with IL­4c at similar molar doses that induced 
maximal levels of proliferation with both reagents (≥80% 
Ki67+ by 48 h; not depicted). Despite near identical levels of 
M proliferation at 24 h, only IL­4c induced RELM (Fig. 7 A) 
or Ym1 (not depicted) production. Furthermore, Fc–CSF­1 
RELM+ pleural Ms in M­specific IL­4R–deficient 
LysMcreIl4ra/lox mice during the later phase of Ls infection 
(Fig. 5 D). Indeed, by day 60 after infection, RELM and 
YM1 expression by Ms is indistinguishable between WT 
and LysMcreIl4ra/lox mice (not depicted). IL­4R expression 
on Ms in the LysMcreIl4ra/lox mice was confirmed by surface 
staining (Fig. 5 D). Thus, IL­4R expression can give Ms a 
competitive advantage during a chronic Th2 inflammatory 
setting such as helminth infection.
Proliferation during infection requires adaptive  
immunity and is localized to the infection site
We have previously established using Rag1/ mice that IL­4– 
driven M proliferation per se does not require adaptive 
immunity (Jenkins et al., 2011). In the context of chronic 
nematode infection, however, M accumulation requires Th2 
cells and MHC class II (Loke et al., 2007). We thus assessed 
the requirement for adaptive immunity in M proliferation 
during infection. There was a dramatic reduction in the num­
ber of F4/80+ Ms in nematode­infected Rag1/ mice 
compared with WT controls, matched by a complete failure 
of the Ms to divide or up­regulate alternative activation 
markers (Fig. 5 E). Consistent with a need for cognate anti­
gen­specific interaction, proliferation and alternative activa­
tion were localized to the site of parasite infection in WT 
animals, with significantly (P < 0.05) elevated responses 
observed in the pleural but not the peritoneal cavity of in­
fected mice (Fig. 5 F).
IL-4–dependent M proliferation, alternative  
activation, and competitive advantage are features  
of intestinal nematode infection
Oral infection of BALB/c mice with the gastrointestinal (GI) 
nematode Heligmosomoides polygyrus bakeri (Hp) leads to inva­
sion of the submucosa of the duodenum where the worms 
undergo developmental maturation. Despite restriction of the 
worms to the GI tract, there is systemic dissemination of  Th2 
cells with selectivity for the peritoneal cavity (Mohrs et al., 
2005). In Hp­infected mice, there was a striking increase in 
proliferation of F4/80High resident Ms by day 7 after infection 
in the peritoneal (Fig. 6 A) but not the pleural cavity (not de­
picted), consistent with the localized M proliferation observed 
squares) and IL-4RCD45.1 (open squares) cells positive for BrdU or Ym1, with each line illustrating paired measurements from individual mice. 
Data are pooled from two experiments, with 11–12 mice/group. ***, P < 0.001 determined by paired Student’s t test. (B) CD45.1 and CD45.2 expression 
gated on all F4/80High pleural Ms from mice in A and graphical presentation of the total number of IL-4R+CD45.1+ (closed squares) and IL-4RCD45.2+/+ 
(open squares) subsets of these cells. *, P < 0.05; **, P < 0.01; and ***, P < 0.001 determined by Kruskal-Wallis test. (C) Frequency of IL-4R+CD45.1+ 
cells within CD115+CD11b+SSCLow blood monocytes and pleural cavity eosinophils (SSCHigh, F4/80Low, MHCII), DCs (CD11cHighMHCIIHigh), and F4/80High 
Ms at days 10 and 16 after infection of mice in A, with lines joining cells of individual mice. (D) Il4ra+/+ (WT), Il4ra/lox (Het), LysMcreIl4ra/lox (Lys), or 
Il4ra/ (/) mice were infected with Ls or left naive, and RELM and IL-4R staining on F4/80High pleural Ms was determined at day 17. Frequen-
cies are means with SEM in parentheses of five to seven mice/group. The emergence of RELM+ Ms in LysMcreIl4ra/lox mice was confirmed in a fur-
ther three independent experiments between days 14 and 60 after infection. (E) C57BL/6 (WT) or Rag1/ (/) mice were infected with Ls, and the 
total number of pleural cavity F4/80High Ms and the proportion incorporating BrdU or expressing Ym1 were determined on day 10, with mean and 
SEM of five mice/group shown. (F) As in E, but both peritoneal (PeC) and pleural (PleC) cavity F4/80High Ms from naive (open circles) or Ls-infected 
C57BL/6 mice were analyzed at 10 d after infection. Data are representative of three experiments with eight mice/group. *, P < 0.05; and **, P < 0.01 
determined by Kruskal-Wallis test. (B and F) Horizontal bars indicate median values.
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Figure 6. IL-4–dependent proliferation occurs during GI nematode infection and provides a competitive advantage to IL-4R+ Ms. 
(A) BALB/c mice were infected orally with Hp, and peritoneal lavage cells were assessed at day 7. Representative flow cytograms of all peritoneal cells 
showing gates and frequencies for all or BrdU+, Ki67+, RELM+ or Ym1+, F4/80High Ms. Data are representative of five experiments. (B) BALB/c (WT) 
or Il4/ (/) mice were infected with Hp (closed symbols) or left naive (open symbols), and the total peritoneal F4/80High Ms and the proportion 
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Nevertheless, IL­4R+ Ms remain reliant on CSF­1 for 
survival after IL­4–driven expansion, as indicated by the re­
duced numbers observed after CSF1R blockade. Seemingly 
at odds with such a requirement, we found that IL­4 treatment 
was accompanied by a sharp down­regulation in M tran­
scription of the CSF1R. However, lower levels of CSF1R 
signaling are required for M survival than are needed for 
their proliferation (Tushinski et al., 1982). CSF­1 is likely 
present in the steady­state serous cavities in greater abundance 
than required for M survival given the evident homeostatic 
CSF­1–dependent proliferation in these sites (Figs. 1 and 4; 
Davies et al., 2013). We suggest that IL­4–mediated down­
regulation of CSF1R reduces local CSF­1 consumption by 
individual cells, thereby maintaining sufficient tissue CSF­1 
levels to allow survival of the expanding M population. 
Such a model would explain how the basal levels of prolifera­
tion and total number of IL­4R Ms in mixed BM chi­
meras appeared to be maintained at near normal steady­state 
levels after treatment with IL­4c (Fig. 2 E) despite the large 
outgrowth of IL­4R+ cells and without a corresponding 
increase in CSF­1 production (Fig. 1 D). Together, our data 
suggest that IL­4 and CSF­1 are entirely distinct in terms of 
proliferation although CSF­1 is still critical for survival in the 
context of IL­4 expansion.
During nematode infection, our data suggest that CSF­1 
plays an early role in M proliferation but is superseded by 
IL­4 presumably upon entry of Th2 cells. Supporting this, 
CSF1R blockade during infection almost completely inhib­
ited proliferation in all WT animals except those exhibiting 
the highest levels of IL­4 exposure, as indicated by the per­
centage of cells expressing alternative activation markers 
(Fig. 4 A). Furthermore, time course analysis during infection 
demonstrated that proliferation occurred before, but only 
peaked after, the onset of alternative activation (Fig. 3 D), 
whereas more sustained and higher proliferation was achieved 
by IL­4R+ than IL­4R cells in infected mixed BM chi­
meric mice (Fig. 5 A). Lastly, the restriction of proliferation 
and M accumulation to the infection site, and the absence 
of any such response in Rag1/ animals (Fig. 5, E and F), 
mirrors our previous findings that Ms fail to accumulate in 
a related nematode infection in the absence of Th2 cells (Loke 
et al., 2007). IL­4 may also contribute to elevated tissue M 
density during infection through additional cell­intrinsic mech­
anisms, for example, by reducing reliance on local glucose 
levels (Vats et al., 2006), inhibiting migration from the tissue 
induced the recruitment of inflammatory cells including neu­
trophils and Ly­6C+ monocytes (Fig. 7 B), consistent with 
its recently described ability to drive proinflammatory che­
mokine production (Tagliani et al., 2011) and acute monocyto­
penia (Ulich et al., 1990). In striking contrast, no inflammatory 
recruitment was seen with IL­4c, consistent with the ability 
of IL­4 to actively down­regulate proinflammatory chemokines 
(Thomas et al., 2012). Thus although CSF­1 and IL­4 both 
induce M proliferation in the tissues, they have otherwise 
markedly different consequences. Additionally, these data dem­
onstrate that elevated CSF­1 signaling is sufficient to stimu­
late heightened proliferation (Fig. 7 A) and accumulation (not 
depicted) of resident Ms in vivo without need for addi­
tional signals that occur during infection/inflammation and 
provide some explanation for the elevated peritoneal M num­
bers seen in the original study of systemic CSF­1 treatment 
of mice (Hume et al., 1988).
DISCUSSION
We previously demonstrated the requirement for IL­4 to 
achieve maximal proliferation of Ms during nematode in­
fection and an absolute requirement for IL­4R for M 
proliferation after IL­4c delivery (Jenkins et al., 2011). Our 
working hypothesis was that IL­4 acted indirectly via an in­
termediate cell, to stimulate production of a M mitogenic 
factor, such as CSF­1, similar to the process by which a vita­
min D3 analogue acts on keratinocytes to stimulate Langer­
hans cell proliferation (Chorro et al., 2009). This hypothesis 
was supported by our preliminary data in which IL­4–driven 
proliferation was observed in mice apparently lacking IL­4R 
on Ms. However, using mixed BM chimeric mice, we dem­
onstrate that M­intrinsic IL­4R signaling is required for 
M proliferation in response to endogenous or exogenous 
IL­4. Furthermore, IL­4–mediated proliferation was entirely 
independent of CSF1R signaling, in contrast to the homeo­
static proliferation of cavity­resident Ms, which is com­
pletely dependent on CSF­1 (Fig. 1, A and B; and Fig. 4 A; 
Davies et al., 2013). Treatment with IL­4c did not increase 
production of CSF­1 in either serum or tissues, consistent 
with an intrinsic and CSF­1–independent effect of IL­4 on 
Ms. Thus, it would appear that IL­4R signaling to Ms 
allows their substantial outgrowth above normal tissue levels 
at least in part by switching them to a CSF­1–independent 
program of proliferation.
positive for BrdU, Ki67, Ym1, and RELM+ was determined on day 7. Data are representative of three experiments with three to four mice per 
group. *, P < 0.05; **, P < 0.01; and ***, P < 0.001 determined by ANOVA. (C) As in B but after treatment of BALB/c mice with anti-CSF1R mAb (CSF1R) or 
rat IgG (IgG) on day 6. (D) Il4ra+/+Cd45.1+Cd45.2+ mice were lethally irradiated and reconstituted for 8 wk with a 50:50 mix of Il4ra+/+Cd45.1+Cd45.2+ and 
Il4ra/Cd45.1nullCd45.2+ congenic BM cells before infection with Hp. The frequency of CD45.1+ cells in different leukocyte subsets in the peritoneal 
cavity in naive (open symbols) and Hp-infected mice (closed symbols) was determined on days 7 and 14 after infection. The graphs show total 
numbers of Il4ra+/+Cd45.1+ and Il4ra/Cd45.1null peritoneal F4/80High Ms obtained in naive (open) and infected (closed) mice at each time point. 
(E) Il4ra/lox (Het), LysMcreIl4ra/lox (Lys), or Il4ra/ (/) mice were infected with Hp, and RELM expression by F4/80High peritoneal Ms was deter-
mined on days 14 and 28. (C–E) Data are from independent experiments performed once and are confirmatory of data from the Ls model. (B–E) Hori-
zontal bars indicate mean values.
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to IL­4R+ Ms in IL­4–treated or nematode­infected mixed 
BM chimeric mice despite abundant IL­10 detectable in the 
pleural lavage fluid during infection (not depicted). It would 
seem that the selective advantage of IL­4R expression leads to 
accrual of a minor non­gene–deleted population, which could 
account for the Ym1+ cells observed in LysMcreIl4ra/lox mice 
during schistosome infection (Dewals et al., 2010). Alterna­
tively, Ms elicited by schistosome eggs may differ qualitatively 
from those found during nematode infection and IL­4c injec­
tion, being capable of Ym1 production in response to IL­10. In 
this respect, schistosome eggs elicit CCR2­dependent inflam­
matory Ms (Chensue et al., 1996; Lu et al., 1998), contrasting 
with the resident­derived cells in our systems (Jenkins et al., 
2011). Furthermore, Il4ra/ and LysMcreIl4ra/lox mice show 
no defect in overall M numbers elicited to schistosome gran­
ulomas (Dewals et al., 2010), perhaps because of the proinflam­
matory nature of the eggs. Therefore, the balance of proliferation 
versus recruitment in Th2 settings almost certainly depends on 
integration of multiple inflammatory signals. Of relevance, 
variation of IL­4c dose and delivery timing suggested that pro­
liferation may only be apparent in environments in which criti­
cal IL­4 thresholds are sustained.
(Thomas et al., 2012), or protecting against apoptosis, as occurs 
in other leukocytes (Wurster et al., 2002). Although the mixed 
Il4ra+/+: Il4ra/ BM mice do not reflect the natural distribu­
tion of IL­4R expression in vivo, they are critically important 
for understanding how cell­intrinsic IL­4R signaling augments 
M numbers during nematode infection. Furthermore, the 
data generated using these mice may be relevant to circum­
stances in which differential IL­4R expression does occur 
(Wermeling et al., 2013).
RELM and Ym1 were used here as surrogate markers of 
IL­4R–experienced Ms. Elsewhere, Ym1 expression has been 
documented in Ms from LysMcreIl4ra/lox mice in the liver 
granulomas surrounding schistosome eggs and peritoneal cav­
ity after injection of schistosome eggs (Dewals et al., 2010). 
Because Ym1 expression is reduced significantly by in vivo 
IL­10 blockage, it was concluded that IL­10 induces M Ym1 
expression in these settings independently of IL­4 (Dewals et al., 
2010). However, we observed a large proportion of serous cav­
ity Ms in LysMcreIl4ra/lox mice expressing Ym1 and RELM 
in response to IL­4c injection and during infection with Ls or 
Hp, with costaining confirming IL­4R expression. Moreover, 
expression of both Ym1 and RELM was exclusively restricted 
Figure 7. CSF-1 but not IL-4 stimulates 
neutrophil and monocyte recruitment 
alongside elevated proliferation of resident 
tissue Ms. (A) BL/6 mice were injected i.p. 
with PBS, Fc–CSF-1, or IL-4c, and Ki67 and 
RELM expression by F4/80High peritoneal Ms 
was determined 24 h later. Representative flow 
cytograms show all live peritoneal lavage cells. 
Data are representative of two independent 
experiments. (B) Total Ly-6C+CD115+ mono-
cytes and Ly-6CIntermediateSSCIntermediate neutro-
phils in peritoneal lavage cells from mice in A 
and representative flow cytograms depicting 
gating strategies. Top flow cytograms also 
depict CD115+Ly6C monocytes/Ms (left 
gate), and bottom flow cytograms show the 
SSCHighLy6CLow eosinophil gate, both of 
which exhibited no change in total number. 
(A and B) Horizontal bars indicate mean values.
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In summary, the impact of IL­4 during infections is likely 
twofold: it increases numbers without the need for recruit­
ment, whereas in the presence of recruitment it insures a 
noninflammatory environment by switching Ms to an alter­
natively activated phenotype. Thus, the numerical advantage 
provided by M IL­4R expression combined with the anti­
inflammatory chemokine profile and alternative activation 
state ultimately leads to the development of a noninflamma­
tory environment to contain worm infection and repair tissue 
regardless of M source.
MATERIALS AND METHODS
Mice. BALB/c Il4/ (Noben­Trauth et al., 1996), Il4ra/, LysMcreIl4ra/lox, 
and Il4ra/lox mice (Herbert et al., 2004), C57BL/6 Il4ra/ and Rag1/ 
mice, and WT controls were bred and maintained in specific pathogen–free 
facilities at the University of Edinburgh. All experiments were permitted 
under a Project License granted by the Home Office UK and were approved 
by the University of Edinburgh Ethical Review Process. Experimental mice 
were age and sex matched. C57BL/6 Il4ra/ mice were generated by back­
crossing from the BALB/c Il4ra/ strain a minimum of nine times. Com­
petitive mixed BM chimeric mice were created by lethally irradiating 
C57BL/6 Cd45.1+Cd45.2+ mice with 11.5 Gy  radiation administered in 
two doses 3 h apart, followed by i.v. injection of with 5 × 106 BM cells de­
pleted of mature T cells using CD90 microbeads (Miltenyi Biotec) and com­
prised of a 1:1 mix of cells from C57BL/6 Cd45.2+/+Il4ra/ mice and 
C57BL/6 Cd45.1+Cd45.2+ mice. Chimeric animals were left for at least 8 wk 
before further experimental manipulation.
Parasites and reagents. Hp and Ls life cycles were maintained, and infec­
tive third­stage larvae (L3) were obtained as described elsewhere (Behnke 
and Wakelin, 1977; Le Goff et al., 2002). Mice were infected with 200 Hp L3 
by oral gavage or 25 Ls L3 by s.c. injection. IL­4–anti–IL­4 mAb complex 
(IL­4c) was prepared as described previously (Finkelman et al., 1993), and 
unless stated otherwise, mice were injected i.p. with 5 µg of recombinant IL­4 
(13.5 kD; PeproTech) complexed to 25 µg 11B11 (Bio X Cell) or 100 µl PBS 
vehicle control on days 0 and 2, and peritoneal and pleural exudate cells were 
harvested on day 4. IL­13–anti–IL­13 complexes were similarly prepared using 
5 µg of recombinant IL­13 (12.3 kD; PeproTech) complexed to 25 µg eBio13A 
(eBioscience). Fc–CSF­1 is a fusion protein of pig CSF­1 with the Fc region 
of pig IgG1A (43.82 kD total) that was produced using mammalian cell line 
expression by Zoetis for D. Hume (UK patent application GB1303537.1). 
CSF­1 was conjugated to Fc for increased stability in vivo. Extensive experi­
ments in mice and pigs reveal that pig CSF­1 is equally active in mice (Gow 
et al., 2012). The presence of endotoxin­like activity in Fc–CSF­1 was tested 
in murine BM­derived Ms. There was no detectable induction of the LPS­
responsive TNF gene under conditions in which LPS induced the gene 
>1,000­fold. Mice were injected i.p. with 20 µg Fc–CSF­1 in PBS. Where speci­
fied, mice were given 1 mg BrdU i.p. 3 h before the experimental end point.
Isolation of cells from the peritoneal and pleural cavity. Mice were 
sacrificed by exsanguination via the brachial artery under terminal anesthesia. 
After sacrifice, pleural or peritoneal cavity exudate cells were obtained by 
washing of the cavity with lavage media comprised of RPMI 1640 contain­
ing 2 mM l­glutamine, 200 U/ml penicillin, 100 µg/ml streptomycin, and 
2 mM EDTA (Invitrogen). The first 2 or 3 ml of lavage wash supernatant 
from the pleural or peritoneal cavities, respectively, was frozen before analysis 
by ELSIA. Worm burden in the pleural lavage fluid of Ls­infected mice was 
determined by counting under a stereomicroscope (MZ9; Leica). Erythro­
cytes were removed by incubating with red blood cell lysis buffer. Cellular 
content of the cavities and organs was assessed by cell counting using a Casy 
TT cell counter (Roche) in combination with multicolor flow cytometry.
Flow cytometry. Equal numbers of cells or 20 µl of blood was stained for 
each sample. Blood samples were mixed and washed with Hank’s buffered 
Steady­state proliferation in naive animals was not influ­
enced by IL­4R signaling in mixed BM chimeric mice, 
LysMcreIl4ra/lox mice, or in global IL­4R–deficient animals, 
demonstrating that IL­4 mediates density of cavity Ms only 
under conditions of inflammation and not homeostasis. IL­4R 
signaling also had little or no bearing on the wholly CSF­1–
dependent elevated proliferation of resident peritoneal Ms 
that occurs during resolution of microbial­induced perito­
nitis (Davies et al., 2013). In this process, however, prolifera­
tion acts simply to restore the M population to its original 
level after depletion during the acute stage of inflammation 
(Davies et al., 2011) and is therefore akin to homeostatic main­
tenance rather than an inflammatory process. In keeping with 
this, the levels of CSF­1 did not differ between naive and 
inflammatory­challenged mice in this study (Davies et al., 2013). 
Elevated levels of circulating CSF­1 do occur in many disease 
states, and administration of CSF­1 can greatly increase tissue 
M numbers in rodents and primates (Hume and MacDonald, 
2012), but it is unclear whether this increase results from the 
outgrowth of resident Ms or recruitment of new monocyte­
derived cells. Using a recombinant Fc–CSF­1 fusion protein, 
we demonstrate that CSF­1 efficiently stimulates proliferation 
of resident peritoneal Ms (Fig. 7 A). Furthermore, during 
nematode infection, we detected an approximate doubling in 
the number of IL­4R–deficient Ms in mixed BM chime­
ras (Fig. 5 A) and in global Il4ra/ mice (Fig. 3 B), mirroring 
the twofold increase in local CSF­1 production (Fig. 4 B). 
Elevated CSF­1 can therefore act during an inflammatory 
episode to increase local numbers of resident tissue Ms and 
could play a more significant role in expansion of resident 
Ms in pathologies in which much higher CSF­1 levels are 
observed (Hamilton, 2008).
Although both IL­4 and CSF­1 elicited proliferation of 
resident Ms, they differed fundamentally in other actions. In 
particular, injection of Fc–CSF­1 also induced recruitment of 
Ly6C+ monocytes and neutrophils, consistent with studies 
elsewhere (Lenda et al., 2003; Tagliani et al., 2011), suggesting 
elevated CSF­1 secretion may act as an emergency stopgap to 
rapidly fill the tissue M compartment. In contrast, we saw no 
evidence of increased recruitment of inflammatory cells after 
IL­4c administration and previously observed recruitment of 
only low numbers during the early stages of Ls infection 
despite the large increase in resident tissue Ms (Jenkins et al., 
2011). CSF1R signaling directly induces production of CCR2 
ligands by tissue Ms to stimulate recruitment of Ly­6C+ 
monocytes (Tagliani et al., 2011), whereas IL­4 down­regulates 
M production of CCL2, CCL7, and CCL3 during tissue 
nematode infection (Thomas et al., 2012). Although the find­
ing that IL­4–mediated proliferation is CSF1R independent 
was at first unexpected, our data suggest that this mechanism 
may have developed as an alternative to a CSF­1 pathway to 
increase numbers of resident Ms without coincident increase 
in monocyte recruitment. This could be seen as an additional 
tissue­protective function of IL­4 beyond induction of the 
immunoregulatory and pro­wound repair phenotype associated 
with alternative activation (Murray and Wynn, 2011).
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M purification and gene expression. Gene expression analysis on Ms 
from IL­4c– or PBS­treated mice was performed on mRNA for which we 
have previously published data (Rückerl et al., 2012). In brief, 24 h after 
treatment of mice with PBS or IL­4c, peritoneal Ms were sorted using a 
FACSAria cell sorter (BD) according to their expression of F4/80+, Siglec­F, 
CD11b+, CD11c, B220, CD3 to purities >90%. Total RNA was then 
isolated using the miRNEasy kit (QIAGEN) according to the manufac­
turer’s instructions, measured using a NanoDrop (Thermo Fisher Scientific), 
and converted to cDNA with BioScript reverse transcription (Bioline) and 
p(dT)15 primers (Roche). Expression levels were quantified using Light­
Cycler 480 SYBR Green I Master (Roche), with measurements performed on 
a LightCycler 480 (Roche). Expression of Csf1r (5­CGAGGGAGACTC­
CAGCTACA­3 and 5­GACTGGAGAAGCCACTGTCC­3) was nor­
malized against Gapdh (5­ATGACATCAAGAAGGTGGTG­3 and 
5­CATACCAGGAAATGAGCTTG­3).
Statistics. Data were log­transformed to achieve normal distribution and 
equal variance where required and then tested using one­way ANOVA or 
Student’s t test. Where equal variance or normal distribution was not achieved, 
Kruskal Wallace or Spearman correlation was used. Paired Student’s t test was 
used to determine differences between proliferation and alternative activation 
of CD45.1+ and CD45.1 Ms obtained from Ls­infected competitive 
mixed BM chimeric mice. Statistics were performed using Prism 5 (GraphPad 
Software). Each data point represents one animal.
Online supplemental material. Fig. S1 shows that Ms in S phase express 
the highest levels of Ki67, such that gating on Ki67High cells provides an accu­
rate estimate of their frequency and provides representative flow cytograms of 
Ki67, RELM, and Ym1 staining on peritoneal and pleural Ms at various 
times after IL­4c injection. Fig. S2 shows the gating strategy used to deter­
mine frequency of M subsets from competitive mixed BM chimera ex­
periments. Online supplemental material is available at http://www.jem.org/ 
cgi/content/full/jem.20121999/DC1.
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